Table 1. Multivariate analysis with Cox proportional hazards model for overall survival.

Factor	Total cases (n = 122)
	Univariate analysis		Multivariate analysis
	Risk ratio label (95% confidence interval)	P	Risk ratio label (95% confidence interval)	P
MMP10 high (score 2)	3.30 (1.67–6.51)	0.001**	2.39 (1.19–4.80)	0.014*
Advanced age (over 50)	1.78 (0.82–3.87)	0.14
Multipara (≥ 2)	1.78 (0.70–3.24)	0.12
Histological subtype
Serous	1.55 (0.82–2.92)	0.17
Cleacell	0.81 (0.40–1.63)	0.55
Endometrioid	0.50 (0.16–1.64)	0.26
Mucinous	0.97 (0.23–4.02)	0.97
Advanced Stage (over FIGO Stage III)	8.02 (2.85–22.59)	< 0.001**
Peritoneal dissemination	4.73 (1.93–9.90)	< 0.001**
Lymph node metastasis	1.48 (0.78–2.81)	0.23
Platinum resistant	12.46 (5.18–29.96)	< 0.001**	5.75 (2.09–15.81)	0.001**
Nonoptimal debulking surgery	7.00 (3.33–14.74)	< 0.001**	2.84 (1.21–6.64)	0.016*

Factor	Advanced cases (n = 74)
	Univariate analysis		Multivariate analysis
	Risk ratio label (95% confidence interval)	P	Risk ratio label (95% confidence interval)	P
MMP10 high (score 2)	2.98 (1.46–6.09)	0.003**	2.98 (1.46–6.12)	0.003**
Advanced age (over 50)	1.38 (0.60–3.16)	0.44
Multipara (≥ 2)	1.89 (0.83–3.65)	0.14
Histological subtype
Serous	0.67 (0.34–1.32)	0.24
Cleacell	2.01 (0.91–4.43)	0.083
Endometrioid	0.68 (0.21–2.24)	0.53
Mucinous	1.81 (0.43–7.65)	0.42
Advanced Stage (over FIGO Stage III)	–	–
Peritoneal dissemination	–	–
Lymph node metastasis	–	–
Platinum resistant	3.93 (1.62–9.54)	0.001**
Nonoptimal debulking surgery	4.71 (1.83–12.14)	0.001**	4.70 (1.82–12.13)	0.001**

Factors correlated with deciding FIGO stages were excluded from advanced case's table. The other absent columns are excluded from final model by step wise method (*P < 0.05, **P < 0.01).